Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.8K
Overview
84.8K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total Synthesis and Antimycobacterial Activity of Ascidiathiazones A and B and Analogues.

The Journal of organic chemistry·2026
Same author

Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants.

Vaccines·2026
Same author

Design and assessment of dimeric trehalose glycolipids as a strategy to enhance Mincle-mediated vaccine adjuvanticity.

Organic & biomolecular chemistry·2026
Same author

The Synthesis of Glycosyl Amides from Unprotected Carbohydrates and Acylsilanes.

Organic letters·2025
Same author

Recent Advances in the Development of Mincle-Targeting Vaccine Adjuvants.

Vaccines·2025
Same author

Synthesis and glycosidase inhibition of 3,4,5-trihydroxypiperidines using a one-pot amination-cyclisation cascade reaction.

Carbohydrate research·2024
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Targeting the MR1-MAIT Cell Axis for Vaccination Against Infectious Disease.

Mattie S M Timmer1,2, Lisa M Connor2,3, Bridget L Stocker1,2

  • 1School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington 6012, New Zealand.

Vaccines
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

Mucosal-associated invariant T (MAIT) cells and their unique T cell receptor (TCR) offer potential for new vaccines. Exploiting the MR1-MAIT cell axis shows promise for infectious disease protection, though challenges remain.

Keywords:
5-OP-RUMAIT cellMR1adjuvantimmune cellinfectious diseaseligandvaccine

More Related Videos

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.6K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Feb 27, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.6K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Disease

Background:

  • Mucosal-associated invariant T (MAIT) cells possess a unique T cell receptor (TCR) and are abundant in the body.
  • MAIT cells are activated by MR1 ligands, presenting an opportunity for vaccine development against infectious diseases.
  • Two vaccination strategies leverage the MR1-MAIT cell axis: pan-vaccination with MR1 ligands and conventional antigen pairing.

Purpose of the Study:

  • To review the potential of the MR1-MAIT cell axis for developing vaccines against infectious diseases.
  • To discuss the mechanisms and challenges associated with MR1-MAIT cell-mediated vaccine adjuvants.
  • To highlight mechanistic studies investigating MAIT cell functions in vaccine contexts.

Main Methods:

  • Review of existing literature on MR1-MAIT cell interactions and vaccination strategies.
  • Analysis of studies using MR1 ligands in murine models for various infections.
  • Examination of challenges, including ligand stability and human translation.

Main Results:

  • Pan-vaccination with MR1 ligands (e.g., 5-OP-RU) enhanced protection in models of bacterial and viral infections, except for *Mycobacterium tuberculosis*.
  • Pairing MR1 ligands with conventional antigens proved effective in models of cholera, influenza, and SARS-CoV-2.
  • Instability of 5-OP-RU and the need for further human studies are key challenges.

Conclusions:

  • The MR1-MAIT cell axis is a promising platform for infectious disease vaccines.
  • Further research is needed to optimize MR1 ligands and understand their translation to human applications.
  • MAIT cell-mediated vaccination strategies hold potential for broad protection against diverse pathogens.